Intellia Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.92-1.89-6.201.90
Price/Sales ratio
12.766.571.180.40
Earnings per Share (EPS)
$-5.32$-5.41$-1.65$5.39

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.75-31.48-9.20-10.24-6.88-7.47-24.25-32.27-5.47-5.62-6.04-6.88
Price/Sales ratio
N/A64.5817.6726.4919.3116.0852.51253.6051.5274.6155.0219.31
Price/Book Value ratio
1.415.791.382.302.112.565.778.052.172.572.322.11
Price/Cash Flow ratio
-3.08-221.428.06-10.60-9.59-6.71-61.02-37.25-8.05-6.86-8.60-9.59
Price/Free Cash Flow ratio
-2.75-90.429.72-9.18-8.69-6.29-56.93-35.25-6.85-6.63-7.32-8.69
Price/Earnings Growth ratio
N/A0.32-0.08-0.31-1.297.40-1.69-0.50-0.070.370.08-1.29
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A-84.81%-93.21%-159.01%-192.81%-151.52%-159.35%79.15%85.47%75.25%N/A-192.81%
Operating Profit Margin
N/A-221.85%-195.15%-266.32%-298.58%-246.77%-235.51%-810.36%-879.03%-1420.51%-879.03%-246.77%
Pretax Profit Margin
N/A-221.85%-191.96%-258.61%-280.41%-230.91%-231.45%-810.49%-909.77%-1326.51%-909.77%-230.91%
Net Profit Margin
N/A-205.11%-191.96%-258.61%-280.41%-215.06%-216.51%-785.76%-940.51%-1326.51%-909.77%-215.06%
Effective Tax Rate
N/A7.54%3.48%4.43%-6.47%6.86%6.45%3.05%-3.37%N/AN/A-6.47%
Return on Assets
-133.79%-15.09%-10.58%-17.95%-24.57%-27.73%-18.56%-20.06%-32.24%-36.98%-31.19%-27.73%
Return On Equity
-189.11%-18.40%-15.07%-22.46%-30.70%-34.34%-23.82%-24.96%-39.67%-45.82%-48.69%-34.34%
Return on Capital Employed
-62.66%-18.76%-11.98%-20.16%-29.62%-35.61%-22.31%-22.91%-32.87%-43.45%-32.87%-35.61%
Liquidity Ratios
Current Ratio
N/AN/A9.1511.318.008.129.59N/AN/AN/A9.618.00
Quick Ratio
4.307.259.1511.318.008.129.598.7910.168.669.458.00
Cash ratio
4.187.088.8810.861.451.602.490.984.131.964.131.45
Days of Sales Outstanding
N/A60.39142.95146.3390.5139.1213.4022.4226.38366.8226.3839.12
Days of Inventory outstanding
N/AN/A0.000.000.000.00-46.46-17.86K-3.34KN/AN/A0.00
Operating Cycle
N/A60.39142.95146.3390.5139.12-33.05-17.84K-3.31K366.82N/A39.12
Days of Payables Outstanding
43.8244.4453.3211.7111.0913.2625.38511.29248.44303.02N/A13.26
Cash Conversion Cycle
N/A15.9589.62134.6179.4225.85-58.44-18.35K-3.56K63.79N/A25.85
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A0.010.000.00N/A0.010.180.18
Debt Equity Ratio
N/AN/AN/AN/AN/A0.020.010.00N/A0.010.230.23
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.08N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/A0.020.010.00N/A0.010.090.09
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-53.63N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A-17.97-8.76-24.69N/A-21.18-2.54-2.54
Company Equity Multiplier
1.411.211.421.251.241.231.281.241.231.231.231.23
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A-0.292.19-2.49-2.01-2.39-0.86-6.80-6.39-10.86-6.39-2.39
Free Cash Flow / Operating Cash Flow Ratio
1.112.440.821.151.101.061.071.051.171.031.171.10
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A-17.97-8.76-24.69N/A-21.18-2.54-2.54
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-17.97-8.76-24.69N/A-21.18-19.97-17.97
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A